Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cambia vs Ketorolac for Severe Migraine
NCT02664116Phase 4Unknown
- Sponsor
- Scripps Health
- Start
- Jan 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of diclofenac in migraine (2 arms), sponsored by Scripps Health. Primary endpoints: Pain relief on a 0-3 scale at 60 months, Pain free response on a 0-3 scale at 2 hours and 1 more. Status: unknown.
02
Drugs
diclofenac
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02664116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02664116.